GB1271302A - New pyridyl-oxadiazole derivatives and process for the preparation thereof and pharmaceutical compositions containing same - Google Patents
New pyridyl-oxadiazole derivatives and process for the preparation thereof and pharmaceutical compositions containing sameInfo
- Publication number
- GB1271302A GB1271302A GB09047/69A GB1904769A GB1271302A GB 1271302 A GB1271302 A GB 1271302A GB 09047/69 A GB09047/69 A GB 09047/69A GB 1904769 A GB1904769 A GB 1904769A GB 1271302 A GB1271302 A GB 1271302A
- Authority
- GB
- United Kingdom
- Prior art keywords
- compositions
- spasmolytic
- agents
- pharmaceutical compositions
- april
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- OLBJUDUHXGRSBY-UHFFFAOYSA-N 4-pyridin-2-yloxadiazole Chemical class O1N=NC(C=2N=CC=CC=2)=C1 OLBJUDUHXGRSBY-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 4
- 239000000812 cholinergic antagonist Substances 0.000 abstract 3
- 230000002048 spasmolytic effect Effects 0.000 abstract 3
- 125000004076 pyridyl group Chemical group 0.000 abstract 2
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 abstract 1
- -1 2-ethyl-4-pyridyl group Chemical group 0.000 abstract 1
- GNEIDVZJZCQSNX-UHFFFAOYSA-N 5-pyridin-2-yloxadiazole Chemical compound N1=NOC(C=2N=CC=CC=2)=C1 GNEIDVZJZCQSNX-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 230000001754 anti-pyretic effect Effects 0.000 abstract 1
- 239000002221 antipyretic Substances 0.000 abstract 1
- 239000003435 antirheumatic agent Substances 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000003995 emulsifying agent Substances 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 239000003326 hypnotic agent Substances 0.000 abstract 1
- 230000000147 hypnotic effect Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000003158 myorelaxant agent Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 239000000080 wetting agent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HUCI000796 | 1968-04-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1271302A true GB1271302A (en) | 1972-04-19 |
Family
ID=10994349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB09047/69A Expired GB1271302A (en) | 1968-04-26 | 1969-04-14 | New pyridyl-oxadiazole derivatives and process for the preparation thereof and pharmaceutical compositions containing same |
Country Status (15)
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0116708A1 (de) * | 1982-12-20 | 1984-08-29 | CASSELLA Aktiengesellschaft | Neue substituierte 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
EP0091726A3 (en) * | 1982-03-03 | 1985-05-15 | Sumitomo Chemical Company, Limited | 5-substituted 1,2,4-oxadiazole derivatives, their preparation and pharmaceutical compositions containing them |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3853893A (en) * | 1973-04-02 | 1974-12-10 | Squibb & Sons Inc | Anthelmintic 5-(pyridyl)-3-(isothiocyanophenyl) oxadiazoles |
HU177086B (en) * | 1975-06-09 | 1981-07-28 | Eszakmagyar Vegyimuevek | Herbicide and fungicide preparation containing substituted 1,2,4-oxadiazolidin-3-one derivatives |
AU780191B2 (en) * | 1999-08-19 | 2005-03-03 | Astrazeneca Ab | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
US6660753B2 (en) * | 1999-08-19 | 2003-12-09 | Nps Pharmaceuticals, Inc. | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
EP1582519A3 (en) * | 1999-08-19 | 2005-12-21 | Nps Pharmaceuticals, Inc. | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
WO2002068417A2 (en) * | 2001-02-21 | 2002-09-06 | Nps Pharmaceuticals, Inc. | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
WO2004014902A2 (en) * | 2002-08-09 | 2004-02-19 | Astrazeneca Ab | Compounds having an activity at metabotropic glutamate receptors |
EP1611123B8 (en) * | 2003-04-09 | 2013-11-13 | Exelixis, Inc. | Tie-2 modulators and methods of use |
EP1625123A4 (en) * | 2003-05-15 | 2007-08-29 | Merck & Co Inc | 3- (2-AMINO-1-AZACYCLYL) -5-ARYL-1,2,4-OXADIAZOLE AS S1P RECEPTOR AGONISTS |
US20060189661A1 (en) * | 2003-11-03 | 2006-08-24 | Wagenen Bradford V | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
WO2005060961A2 (en) * | 2003-12-18 | 2005-07-07 | Astrazeneca Ab | Treatment of transient lower esophageal sphincter relaxations (tlesrs) and gastro-esophageal reflux disease (gerd) |
AU2004303604B2 (en) * | 2003-12-24 | 2011-03-24 | Prosidion Limited | Heterocyclic derivatives as GPCR receptor agonists |
WO2005077368A2 (en) * | 2004-02-03 | 2005-08-25 | Astrazeneca Ab | Treatment of gastro-esophageal reflux disease (gerd) |
AU2006239418A1 (en) * | 2005-04-26 | 2006-11-02 | Neurosearch A/S | Novel oxadiazole derivatives and their medical use |
IL169855A (en) * | 2005-07-25 | 2014-05-28 | Elta Systems Ltd | A system and method for locating a receiver location |
DK1907382T3 (en) | 2005-07-26 | 2015-08-31 | Bial Portela & Ca Sa | Nitrocatecholderivater comt inhibitors as |
EP1845097A1 (en) | 2006-04-10 | 2007-10-17 | Portela & Ca., S.A. | Oxadiazole derivatives as COMT inhibitors |
NZ576060A (en) * | 2006-09-07 | 2011-11-25 | Actelion Pharmaceuticals Ltd | Pyridin-4-yl derivatives as immunomodulating agents |
RU2454413C2 (ru) * | 2006-09-08 | 2012-06-27 | Актелион Фармасьютиклз Лтд | Производные пиридин-3-ила в качестве иммуномодулирующих агентов |
US8524746B2 (en) * | 2007-01-31 | 2013-09-03 | Bial-Portela & Ca., S.A. | Dosage regimen for COMT inhibitors |
CN101627034B (zh) * | 2007-03-16 | 2013-05-15 | 埃科特莱茵药品有限公司 | 氨基-吡啶衍生物作为s1p1/edg1受体激动剂 |
HRP20110449T1 (hr) * | 2007-08-17 | 2011-07-31 | Actelion Pharmaceuticals Ltd. | Derivati piridina kao modulatori receptora s1p1/edg1 |
BRPI0908340A2 (pt) * | 2008-02-28 | 2018-12-26 | Bial Portela & Ca Sa | composição farmacêutica para fármacos pouco solúveis |
WO2009109906A1 (en) * | 2008-03-06 | 2009-09-11 | Actelion Pharmaceuticals Ltd | Pyridine compounds |
CN102015695B (zh) * | 2008-03-07 | 2014-08-27 | 埃科特莱茵药品有限公司 | 吡啶-2-基衍生物 |
AU2009226221A1 (en) | 2008-03-17 | 2009-09-24 | Bial - Portela & Ca., S.A. | Crystal forms of 5- [3- (2, 5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl) [1,2,3] oxadiazol-5-yl] -3-nit robenzene-1, 2-diol |
ES2813368T3 (es) | 2008-05-14 | 2021-03-23 | Scripps Research Inst | Nuevos moduladores de receptores de fosfato de esfingosina |
BRPI1008326A2 (pt) | 2009-02-10 | 2015-08-25 | Divergence Inc | Composições e métodos para controlar nanatódeos |
DK2413913T3 (da) * | 2009-04-01 | 2022-06-13 | Bial Portela & Ca Sa | Farmaceutiske formuleringer omfattende nitrocatecholderivater og fremgangsmåder til fremstilling deraf |
CA2757411C (en) * | 2009-04-01 | 2017-06-27 | Teofilo Cardoso De Vasconcelos | Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof |
TWI410421B (zh) | 2009-07-16 | 2013-10-01 | Actelion Pharmaceuticals Ltd | 吡啶-4-基衍生物 |
MA34910B1 (fr) | 2011-01-19 | 2014-02-01 | Actelion Pharmaceuticals Ltd | Dérivés de 2-methoxy-pyridin-4-yl |
US20140045900A1 (en) | 2011-02-11 | 2014-02-13 | Bial-Portela & Ca, S.A. | Administration regime for nitrocatechols |
PT2791134T (pt) | 2011-12-13 | 2019-12-18 | BIAL PORTELA & Cª S A | Composto químico útil como intermediário para a preparação de um inibidor de catecol-o-metiltransferase |
WO2014127195A1 (en) | 2013-02-15 | 2014-08-21 | Monsanto Technology Llc | 3,5-disubstituted-4,5-dihydro-1,2,4-oxadiazoles for controlling nematode pests |
JP2018500300A (ja) | 2014-11-28 | 2018-01-11 | ノヴィファーマ,エス.アー. | パーキンソン病を遅延させるための医薬 |
PL3298008T3 (pl) | 2015-05-20 | 2020-05-18 | Idorsia Pharmaceuticals Ltd | Krystaliczna postać związku, (S)-3-{4-[5-(2-cyklopentylo-6-metoksypirydyn-4-ylo)-[1,2,4]oksadiazol-3-ilo]-2-etylo-6-metylofenoksy}propano-1,2-diolu |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL120029C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1959-09-29 | |||
US3227725A (en) * | 1962-04-17 | 1966-01-04 | Union Carbide Corp | Certain 3,5-disubstituted 1,2,4-oxadiazole compounds |
-
1969
- 1969-04-08 IL IL31990A patent/IL31990A/xx unknown
- 1969-04-08 US US815520A patent/US3647809A/en not_active Expired - Lifetime
- 1969-04-14 GB GB09047/69A patent/GB1271302A/en not_active Expired
- 1969-04-18 AT AT375469A patent/AT292727B/de not_active IP Right Cessation
- 1969-04-18 AT AT815670A patent/AT292728B/de not_active IP Right Cessation
- 1969-04-19 DE DE19691920037 patent/DE1920037A1/de active Pending
- 1969-04-24 FR FR696912994A patent/FR2007529B1/fr not_active Expired
- 1969-04-24 CH CH627569A patent/CH540925A/de not_active IP Right Cessation
- 1969-04-24 CH CH1476972A patent/CH542232A/de not_active IP Right Cessation
- 1969-04-25 PL PL1969133199A patent/PL79435B1/pl unknown
- 1969-04-25 CA CA049,755A patent/CA954858A/en not_active Expired
- 1969-04-25 SE SE05909/69A patent/SE368576B/xx unknown
- 1969-04-25 BR BR208381/69A patent/BR6908381D0/pt unknown
- 1969-04-25 NL NL6906401A patent/NL6906401A/xx unknown
- 1969-04-25 BE BE732131D patent/BE732131A/xx unknown
- 1969-04-25 NO NO1733/69A patent/NO124253B/no unknown
- 1969-04-25 JP JP44032259A patent/JPS4824394B1/ja active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0091726A3 (en) * | 1982-03-03 | 1985-05-15 | Sumitomo Chemical Company, Limited | 5-substituted 1,2,4-oxadiazole derivatives, their preparation and pharmaceutical compositions containing them |
US4618617A (en) * | 1982-03-03 | 1986-10-21 | Sumitomo Chemical Company, Limited | Novel 5-substituted 1,2,4,-oxadiazole derivatives and preparation thereof |
EP0116708A1 (de) * | 1982-12-20 | 1984-08-29 | CASSELLA Aktiengesellschaft | Neue substituierte 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
US4558058A (en) * | 1982-12-20 | 1985-12-10 | Cassella Aktiengesellschaft | Substituted 1,4-dihydropyridines and their use as medicaments |
Also Published As
Publication number | Publication date |
---|---|
AT292728B (de) | 1971-09-10 |
IL31990A0 (en) | 1969-06-25 |
JPS4824394B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1973-07-20 |
CH542232A (de) | 1973-11-15 |
SE368576B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1974-07-08 |
PL79435B1 (en) | 1975-06-30 |
BR6908381D0 (pt) | 1973-02-08 |
CA954858A (en) | 1974-09-17 |
NL6906401A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1969-10-28 |
FR2007529B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1973-03-16 |
AT292727B (de) | 1971-09-10 |
DE1920037A1 (de) | 1970-11-12 |
IL31990A (en) | 1974-05-16 |
NO124253B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1972-03-27 |
CH540925A (de) | 1973-08-31 |
FR2007529A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1970-01-09 |
BE732131A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1969-10-01 |
US3647809A (en) | 1972-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1271302A (en) | New pyridyl-oxadiazole derivatives and process for the preparation thereof and pharmaceutical compositions containing same | |
GB1171509A (en) | Pyridine Derivatives | |
GB1034939A (en) | Isoxazole derivative and processes for its production | |
GB1174411A (en) | Novel Benzothiophen Compounds, Compositions containing them and processes for their manufacture | |
ES484718A1 (es) | Un procedimiento para la preparacion de benzopiranos. | |
GB1290881A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
GB1141936A (en) | Improvements in or relating to benzimidazole derivatives | |
GB1084150A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
GB1351505A (en) | Terpene derivatives method for their preparation and applications thereof | |
GB1252286A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
GB1181967A (en) | Novel Picoline Derivatives and a Method for the Production Thereof | |
GB1352392A (en) | Phenylisopropylamine derivatives | |
GB1353486A (en) | Benzodiazepine derivatives | |
ES363591A1 (es) | Un procedimiento para la produccion de derivados de fenile-tilamina. | |
GB1138315A (en) | 2-amino-benzylamines | |
GB1036420A (en) | Medicinally useful isoquinoline derivatives and pharmaceutical preparations containing same | |
IE39042L (en) | Ergoline derivatives | |
GB1181295A (en) | Improvements in or relating to Naphthalene Derivatives and the Manufacture Thereof | |
GB1377610A (en) | 5-piperidine-4-spiro- oxazolidinones method for their preparation and applications thereof | |
GB1227967A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
GB1484470A (en) | Pharmaceutical compositions | |
IE34313L (en) | 2-hydroxy-5-aminobenzamides | |
GB1171859A (en) | 00,11-Epoxy-10,11-Dihydro-5H-Dibenzo[a,d] Cycloheptene-5-Carboxamides | |
GB1159430A (en) | New Derivatives of 11 H-Dibenzo[1,2,5] Triazepine and their Salts and process for the preparation thereof | |
GB1280244A (en) | Serum triglyceride-lowering compositions |